Clinical context A client with chronic kidney disease is receiving flucytosine for a serious fungal infection; the nurse compares renal dosing, serum concentration, blood counts, and liver findings before the next dose. A client with chronic kidney disease is receiving flucytosine. Highlight the findings that require prompt toxicity follow-up.
Highlight in Table
Choose your responses, then check the answer.
Explanation
Renal accumulation, an excessive serum concentration, new cytopenias, and liver injury require prompt flucytosine dose and toxicity evaluation.
Quick answer Link kidney clearance to serum level, marrow, and liver toxicity.
Why this is correct Flucytosine is primarily eliminated by the kidneys. Accumulation can produce severe leukopenia, thrombocytopenia, hepatic injury, and gastrointestinal toxicity, so renal dosing and concentration monitoring are essential.
Easy analogy or mental picture Build a medication-safety chain: identify the new cue, connect it to the drug mechanism or labeled limitation, stop preventable exposure, stabilize the client, and verify a measurable response.
Memory hook Drug, urgent cue, protective action, and reassessment endpoint.
NCLEX decision rule Choose the action that prevents the most immediate medication-related harm while preserving indicated treatment and required monitoring.
Why the other choices are wrong Options that continue a suspect exposure, normalize a labeled danger cue, substitute an unauthorized dose, or delay escalation leave the client at risk.
Clinical contextA client with chronic kidney disease is receiving flucytosine for a serious fungal infection; the nurse compares renal dosing, serum concentration, blood counts, and liver findings before the next dose.